Literature DB >> 9462756

Silicone gel-filled breast implants and connective tissue diseases.

A J Park1, R J Black, N S Sarhadi, U Chetty, A C Watson.   

Abstract

Recent worldwide press and media speculation that silicone implants may be linked to an increased incidence of breast cancer, other cancers, and connective tissue diseases-particularly systemic sclerosis-is a current cause for concern to the medical profession and public alike. We conducted a cross-sectional study of the prevalence of connective tissue diseases, as well as signs and symptoms associated with these conditions, in women who had received a silicone gel-filled breast implant for either breast augmentation or breast reconstruction following mastectomy for breast cancer compared with women without implants in South East Scotland. We compared 317 patients who had had a silicone gel-filled breast implant inserted with matched controls. We found no increased incidence of antinuclear antibodies or rheumatoid factor in the study groups. We detected one case of rheumatoid arthritis in the reconstruction group and one in matched controls, but no cases of any other connective tissue disease. No cases were found among the augmentation patients or their controls. No differences were found in symptoms or physical signs of connective tissue diseases between the study patients and their controls. This study has failed to find any case for a link between silicone gel-filled breast implants and connective tissue diseases.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9462756     DOI: 10.1097/00006534-199802000-00001

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  11 in total

Review 1.  Breast implants and illness: a model of psychological factors.

Authors:  D M Dush
Journal:  Ann Rheum Dis       Date:  2001-07       Impact factor: 19.103

2.  Breast cancer after augmentation mammoplasty with silicone gel-filled implant: a case report.

Authors:  M Tun; M Madhavan
Journal:  Malays J Med Sci       Date:  1999-07

Review 3.  Breast implant design.

Authors:  G Patrick Maxwell; Allen Gabriel
Journal:  Gland Surg       Date:  2017-04

Review 4.  The Evolution of Breast Implants.

Authors:  Christodoulos Kaoutzanis; Julian Winocour; Jacob Unger; Allen Gabriel; G Patrick Maxwell
Journal:  Semin Plast Surg       Date:  2019-10-17       Impact factor: 2.314

Review 5.  Silicone breast implants and connective tissue disease: no association.

Authors:  Loren Lipworth; Lisbet R Holmich; Joseph K McLaughlin
Journal:  Semin Immunopathol       Date:  2011-01-10       Impact factor: 9.623

6.  Induction of hypergammaglobulinemia and macrophage activation by silicone gels and oils in female A.SW mice.

Authors:  J O Naim; M Satoh; N A Buehner; K M Ippolito; H Yoshida; D Nusz; L Kurtelawicz; S F Cramer; W H Reeves
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

Review 7.  Breast implant illness: a topic in review.

Authors:  Jordan Kaplan; Rod Rohrich
Journal:  Gland Surg       Date:  2021-01

8.  Prospective cohort study of breast implants and the risk of connective-tissue diseases.

Authors:  I-Min Lee; Nancy R Cook; Nancy A Shadick; Eduardo Pereira; Julie E Buring
Journal:  Int J Epidemiol       Date:  2010-10-13       Impact factor: 7.196

9.  Compromised production of extracellular matrix in mice lacking secreted protein, acidic and rich in cysteine (SPARC) leads to a reduced foreign body reaction to implanted biomaterials.

Authors:  Pauli Puolakkainen; Amy D Bradshaw; Themistoklis R Kyriakides; May Reed; Rolf Brekken; Thomas Wight; Paul Bornstein; Buddy Ratner; E Helene Sage
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

10.  Are the autoimmune/inflammatory syndrome induced by adjuvants (ASIA) and the undifferentiated connective tissue disease (UCTD) related to each other? A case-control study of environmental exposures.

Authors:  F Scanzi; L Andreoli; M Martinelli; M Taraborelli; I Cavazzana; N Carabellese; R Ottaviani; F Allegri; F Franceschini; N Agmon-Levin; Y Shoenfeld; Angela Tincani
Journal:  Immunol Res       Date:  2017-02       Impact factor: 4.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.